Monday 30 January 2017

UK patients losing out in access to cancer drugs

Data shows ‘incomprehensible price rises’

Related items from OnMedica

75% of reappraised CDF drugs approved for NHS
Rising costs of generic medications
Pfizer fined a record £84.2m for overcharging
NHS cancer patients still denied treatments available in other countries
Study shows huge global variation in cancer drug costs
via OnMedica News Read More Here.. Lake forest health and fitness http://ift.tt/2kFrhY7

No comments:

Post a Comment